PENICILLIN-VK
Details
- Status
- Prescription
- First Approved
- 1968-07-03
- Routes
- ORAL
- Dosage Forms
- TABLET, FOR SOLUTION
PENICILLIN-VK Approval History
What PENICILLIN-VK Treats
4 indicationsPENICILLIN-VK is approved for 4 conditions since its original approval in 1968. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Streptococcal Infections
- Scarlet Fever
- Erysipelas
- Pneumococcal Infections
Drugs Similar to PENICILLIN-VK
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
PENICILLIN-VK FDA Label Details
ProIndications & Usage
To reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin V potassium and other antibacterial drugs, penicillin V potassium should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Penicillin V potassium tablets are indicated in...
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.